| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $169.0M | — | +4.6% |
| Gross Profit | $44.7M | — | +9.4% |
| R&D Expense | $221K | — | -26.1% |
| SG&A Expense | $37.0M | — | +3.7% |
| Operating Income | $4.7M | — | +562.6% |
| Pre-tax Income | $2.7M | — | +163.1% |
| Income Tax | $378K | — | +132.4% |
| Net Income | $2.4M | — | +175.0% |
| EPS (Basic) | $0.08 | — | +180.0% |
| EPS (Diluted) | $0.07 | — | +170.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $25.0M | -10.8% | +34.8% |
| Accounts Receivable | $151.4M | -2.1% | +18.1% |
| Inventory | $15.3M | +9.1% | +8.0% |
| Current Assets | $210.9M | -2.5% | +19.8% |
| Total Assets | $572.7M | -1.1% | +8.7% |
| Current Liabilities | $116.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.8M | — | -50.2% |
| Capital Expenditures | $6.0M | — | +31.0% |
| Investing Cash Flow | -$5.6M | — | -2.7% |
| Financing Cash Flow | -$349K | — | +50.3% |
| Free Cash Flow | -$3.2M | — | -389.8% |
| -0.6% |
| Long-term Debt | $181.4M | +1.9% | +5.5% |
| Total Liabilities | $339.1M | -1.2% | +3.4% |
| Stockholders' Equity | $233.2M | -0.8% | +17.4% |